Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Video Video | 12 September 2023 Diagnostics Time for $5 Campaign video Technical brief | 12 September 2023 Diagnostics “Time for $5” Campaign: Questions and Answers Time for $5 Campaign logo Press release Press release | 12 September 2023 Diagnostics Tuberculosis Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need 6 min Research article Research article | 11 September 2023 Tuberculosis The Lancet Child & Adolescent Health: Reversing the neglect of children and adolescents affected by tuberculosis Time for $5 - Sign up to newsletter 07 September 2023 Campaign Newsletter Photo credit: Njiiri Karago/MSF Press release Press release | 17 August 2023 HIV/AIDS MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA 4 min Video Video | 17 August 2023 HIV/AIDS Testimonies for access to HIV prevention drug CAB-LA 1 min Photo credit: Jan-Joseph Stok Letter Letter | 17 August 2023 HIV/AIDS Open letter to ViiV to improve access to HIV prevention drug CAB-LA 1 min Load More
Time for $5 Campaign logo Press release Press release | 12 September 2023 Diagnostics Tuberculosis Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need 6 min
Research article Research article | 11 September 2023 Tuberculosis The Lancet Child & Adolescent Health: Reversing the neglect of children and adolescents affected by tuberculosis
Photo credit: Njiiri Karago/MSF Press release Press release | 17 August 2023 HIV/AIDS MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA 4 min
Photo credit: Jan-Joseph Stok Letter Letter | 17 August 2023 HIV/AIDS Open letter to ViiV to improve access to HIV prevention drug CAB-LA 1 min
